D
Design Therapeutics, Inc.
DSGN · NASDAQ · Healthcare · 926M
Price · close
$14.99
-3.66% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.0×
Enterprise value / EBITDAEV/EBITDA
-12.2×
Free cash flow yieldFCF yield
-6.3%
Return on equityROE
-32.8%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.2×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.